No abstract available
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Allografts
-
Anemia, Aplastic / etiology
-
Anemia, Aplastic / therapy*
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antigens, CD19 / adverse effects
-
Antigens, CD19 / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biological Products
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Gemcitabine
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Immunotherapy, Adoptive / adverse effects*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / therapy*
-
Male
-
Melphalan / administration & dosage
-
Middle Aged
-
Oxaliplatin / administration & dosage
-
Prednisone / administration & dosage
-
Recurrence
-
Rituximab / administration & dosage
-
Salvage Therapy / adverse effects*
-
Transplantation, Autologous
-
Vincristine / administration & dosage
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
Antigens, CD19
-
Biological Products
-
Cytarabine
-
Oxaliplatin
-
Deoxycytidine
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
tocilizumab
-
Melphalan
-
axicabtagene ciloleucel
-
Carmustine
-
Prednisone
-
Gemcitabine
Supplementary concepts
-
BEAM regimen
-
CHOP protocol